Xingguang Luο

5.1k total citations
170 papers, 3.6k citations indexed

About

Xingguang Luο is a scholar working on Molecular Biology, Genetics and Psychiatry and Mental health. According to data from OpenAlex, Xingguang Luο has authored 170 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 48 papers in Genetics and 40 papers in Psychiatry and Mental health. Recurrent topics in Xingguang Luο's work include Genetic Associations and Epidemiology (41 papers), Alcohol Consumption and Health Effects (21 papers) and Schizophrenia research and treatment (19 papers). Xingguang Luο is often cited by papers focused on Genetic Associations and Epidemiology (41 papers), Alcohol Consumption and Health Effects (21 papers) and Schizophrenia research and treatment (19 papers). Xingguang Luο collaborates with scholars based in United States, China and Estonia. Xingguang Luο's co-authors include Joel Gelernter, Lingjun Zuo, Henry R. Kranzler, Bao‐Zhu Yang, Chiang‐Shan R. Li, Hongyu Zhao, Yunlong Tan, Jaakko Lappalainen, Huiping Zhang and John H. Krystal and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Water Research.

In The Last Decade

Xingguang Luο

159 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingguang Luο United States 32 1.1k 882 735 593 561 170 3.6k
Falk W. Lohoff United States 37 1.3k 1.2× 1.1k 1.3× 698 0.9× 553 0.9× 631 1.1× 142 4.1k
Helge Frieling Germany 35 1.3k 1.2× 665 0.8× 406 0.6× 398 0.7× 520 0.9× 215 4.2k
Takuya Saito Japan 26 878 0.8× 956 1.1× 698 0.9× 669 1.1× 983 1.8× 105 3.6k
Jaakko Lappalainen United States 31 1.1k 1.0× 2.0k 2.2× 403 0.5× 400 0.7× 607 1.1× 80 4.0k
Ru‐Band Lu Taiwan 31 556 0.5× 664 0.8× 519 0.7× 291 0.5× 875 1.6× 110 2.7k
Peter Zill Germany 39 1.2k 1.1× 1.8k 2.0× 606 0.8× 647 1.1× 1.0k 1.9× 131 5.1k
Norbert Dahmen Germany 32 736 0.7× 571 0.6× 231 0.3× 829 1.4× 625 1.1× 107 3.2k
Rainald Mößner Germany 37 1.6k 1.4× 2.1k 2.4× 535 0.7× 705 1.2× 804 1.4× 99 5.2k
Anthony L. Hinrichs United States 26 1.1k 0.9× 644 0.7× 611 0.8× 184 0.3× 242 0.4× 57 2.8k
Terry Ritchie United States 27 787 0.7× 1.3k 1.5× 387 0.5× 415 0.7× 589 1.0× 46 2.8k

Countries citing papers authored by Xingguang Luο

Since Specialization
Citations

This map shows the geographic impact of Xingguang Luο's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingguang Luο with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingguang Luο more than expected).

Fields of papers citing papers by Xingguang Luο

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingguang Luο. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingguang Luο. The network helps show where Xingguang Luο may publish in the future.

Co-authorship network of co-authors of Xingguang Luο

This figure shows the co-authorship network connecting the top 25 collaborators of Xingguang Luο. A scholar is included among the top collaborators of Xingguang Luο based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingguang Luο. Xingguang Luο is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Xiangtian, Chaochao Luo, Wei Meng, et al.. (2025). Deciphering the Oncogenic Landscape of Hepatocytes Through Integrated Single‐Nucleus and Bulk RNA‐Seq of Hepatocellular Carcinoma. Advanced Science. 12(14). e2412944–e2412944. 1 indexed citations
3.
4.
Theeke, Laurie A., et al.. (2024). Plasma Proteomic Biomarkers in Alzheimer’s Disease and Cardiovascular Disease: A Longitudinal Study. International Journal of Molecular Sciences. 25(19). 10751–10751. 4 indexed citations
5.
Chen, Ying, Xingguang Luο, Chenxi Wang, et al.. (2024). Clinical features and prognostic biomarkers in patients with SMARCA4-mutated non-small cell lung cancer. Translational Lung Cancer Research. 13(8). 1938–1949. 1 indexed citations
6.
Liu, Ying, et al.. (2024). Feature Selection and Machine Learning Approaches in Prediction of Current E-Cigarette Use Among U.S. Adults in 2022. International Journal of Environmental Research and Public Health. 21(11). 1474–1474. 1 indexed citations
7.
Luo, Jiali, Zhiqiang Xing, Xingguang Luο, et al.. (2023). DNMT1 SNPs (rs2114724 and rs2228611) associated with positive symptoms in Chinese patients with schizophrenia. Annals of General Psychiatry. 22(1). 40–40.
8.
Wang, Kesheng, Chun Xu, Laurie A. Theeke, et al.. (2022). Linear Mixed Model Analysis of Polygenic Hazard Score on Verbal Memory Decline in Alzheimer’s Disease. Nursing Research. 72(1). 66–73. 1 indexed citations
9.
Zeng, Chen, Xingguang Luο, Ying Su, et al.. (2022). Hsa_circ_0006692 Promotes Lung Cancer Progression via miR-205-5p/CDK19 Axis. Genes. 13(5). 846–846. 12 indexed citations
10.
Zhang, Ping, Junchao Huang, Yanfang Zhou, et al.. (2021). Kynurenine metabolism and metabolic syndrome in patients with schizophrenia. Journal of Psychiatric Research. 139. 54–61. 10 indexed citations
11.
Liang, Sixiang, Kaizhong Xue, Wenchen Wang, et al.. (2020). Altered brain function and clinical features in patients with first-episode, drug naïve major depressive disorder: A resting-state fMRI study. Psychiatry Research Neuroimaging. 303. 111134–111134. 25 indexed citations
12.
Luο, Xingguang, Xingguang Luο, Xiaoyun Guo, et al.. (2020). Significant, replicable, and functional associations between KTN1 variants and alcohol and drug codependence. Addiction Biology. 26(2). e12888–e12888. 7 indexed citations
13.
Liang, Sixiang, Xiaojuan Ma, Jian Zhang, et al.. (2020). Psychometric properties of the MATRICS Consensus Cognitive Battery (MCCB) in Chinese patients with major depressive disorder. Journal of Affective Disorders. 265. 132–138. 38 indexed citations
14.
Wang, Wenchen, et al.. (2020). Associations between brain‐derived neurotrophic factor and cognitive impairment in panic disorder. Brain and Behavior. 10(12). e01885–e01885. 7 indexed citations
15.
Yu, Ting, Yanli Li, Fengmei Fan, et al.. (2018). Decreased Gray Matter Volume of Cuneus and Lingual Gyrus in Schizophrenia Patients with Tardive Dyskinesia is Associated with Abnormal Involuntary Movement. Scientific Reports. 8(1). 12884–12884. 25 indexed citations
16.
Zuo, Lingjun, Rolando García-Milian, Xiaoyun Guo, et al.. (2016). Replicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence. Genes. 7(11). 95–95. 3 indexed citations
17.
Kong, Lingtao, Kaiyuan Chen, Fay Y. Womer, et al.. (2013). Sex differences of gray matter morphology in cortico-limbic-striatal neural system in major depressive disorder. Journal of Psychiatric Research. 47(6). 733–739. 68 indexed citations
18.
Xiu, Meihong, Colin N. Haile, Songqing He, et al.. (2012). Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study. Psychological Medicine. 43(8). 1651–1660. 34 indexed citations
19.
Zuo, Lingjun, Joel Gelernter, Henry R. Kranzler, et al.. (2009). ADH1A variation predisposes to personality traits and substance dependence. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 153B(2). 376–386. 13 indexed citations
20.
Zuo, Lingjun, Henry R. Kranzler, Xingguang Luο, et al.. (2008). Interaction between Two Independent CNR1 Variants Increases Risk for Cocaine Dependence in European Americans: A Replication Study in Family-Based Sample and Population-Based Sample. Neuropsychopharmacology. 34(6). 1504–1513. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Falk W. Lohoff Breakdown of academic impact, for papers by Helge Frieling Breakdown of academic impact, for papers by Takuya Saito Breakdown of academic impact, for papers by Jaakko Lappalainen Breakdown of academic impact, for papers by Ru‐Band Lu Breakdown of academic impact, for papers by Peter Zill Breakdown of academic impact, for papers by Norbert Dahmen Breakdown of academic impact, for papers by Rainald Mößner Breakdown of academic impact, for papers by Anthony L. Hinrichs Breakdown of academic impact, for papers by Terry Ritchie
Rankless by CCL
2026